Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PEPD | P12955 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20680 | 1.00 | PEPD (0.54) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL1805083 | 1.00 | PEPD (0.54) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL38660911 | 1.00 | PEPD (0.54) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL1680973 | 1.00 | PEPD (0.54) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL4818635 | 1.00 | PEPD (0.54) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL2515289 | 1.00 | PEPD (0.54) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL150817 | 1.00 | PEPD (0.54) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL23573909 | 0.97 | PEPD (0.52) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL1964404 | 0.97 | PEPD (0.52) | PEPDALDH1A1LMNAMEN1BLM | |
| SCHEMBL20603957 | 0.97 | PEPD (0.52) | PEPDALDH1A1LMNAMEN1BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 933 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441745-B2 | Processes and compounds | RADIUS PHARMACEUTICALS, INC. (US) | 2025-10-14 | — | — | US | claimed |
| CN-119775208-A | Chiral bisimidazoline ligand containing cyclohexane skeleton structure and preparation method thereof | 北京化工大学 | 2025-04-08 | — | — | CN | claimed |
| CN-117940526-A | Adhesive composition and adhesive sheet | 爱天思株式会社 | 2024-04-26 | — | — | CN | claimed |
| CN-115504951-B | Method for preparing hexahydrophthalide by hydrogenating hexahydrophthalic anhydride | 大连理工大学 | 2024-02-13 | — | — | CN | claimed |
| CN-117143348-A | Metal-MOF composite material and preparation method and application thereof | 浙江大学杭州国际科创中心 | 2023-12-01 | — | — | CN | claimed |
| CN-112351967-B | Process for preparing high purity cis-cyclohexane-1,2-dicarboxylic acid salts | 美利肯公司 | 2023-08-22 | — | — | CN | claimed |
| WO-2023042789-A1 | ADHESIVE COMPOSITION AND ADHESIVE SHEET | 東洋インキＳＣホールディングス株式会社 | 2023-03-23 | — | — | WO | claimed |
| US-20220162233-A1 | PROCESSES AND COMPOUNDS | RADIUS HEALTH, INC. | 2022-05-26 | — | — | US | claimed |
| US-11332700-B2 | Use of branched polyesters based on citric acid as additive in washing compositions, cleaners, detergents or a formulation for water treatment | BASF SE (DE) | 2022-05-17 | — | — | US | claimed |
| EP-3924328-A1 | PROCESSES AND COMPOUNDS | Radius Pharmaceuticals, Inc. (US) | 2021-12-22 | — | — | EP | claimed |
| EP-0231373-A1 | A PROCESS FOR THE PRODUCTION OF A LIQUID CRYSTALLINE EXTENDED CHAIN POLYMER COMPOSITION. | COMMTECH INT (US) | 1987-08-12 | — | — | EP | claimed |
| US-4661516-A | WATER SOLUBLE, ANTITUMOR AGENTS | RESEARCH CORPORATION (US) | 1987-04-28 | — | — | US | claimed |
| WO-1987000844-A1 | A PROCESS FOR THE PRODUCTION OF A LIQUID CRYSTALLINE EXTENDED CHAIN POLYMER COMPOSITION | COMMTECH INTERNATIONAL (US) | 1987-02-12 | — | — | WO | claimed |
| WO-1985004178-A1 | LIQUID CRYSTALLINE POLYMER COMPOSITIONS, PROCESS, AND PRODUCTS | SRI INTERNATIONAL (US) | 1985-09-26 | — | — | WO | claimed |
| US-4533693-A | ANISOTROPIC; FIBERS, FILMS | SRI INTERNATIONAL (US) | 1985-08-06 | — | — | US | claimed |
| EP-0119271-A4 | LIQUID CRYSTALLINE POLYMER COMPOSITIONS, PROCESS, AND PRODUCTS. | STANFORD RES INST INT (US) | 1985-07-01 | — | — | EP | claimed |
| EP-0119271-A1 | LIQUID CRYSTALLINE POLYMER COMPOSITIONS, PROCESS, AND PRODUCTS. | STANFORD RES INST INT (US) | 1984-09-26 | — | — | EP | claimed |
| EP-0119192-A1 | LIQUID CRYSTALLINE POLYMER COMPOSITIONS, PROCESS, AND PRODUCTS | SRI INTERNATIONAL (US) | 1984-09-26 | — | — | EP | claimed |
| WO-1984001160-A1 | LIQUID CRYSTALLINE POLYMER COMPOSITIONS, PROCESS, AND PRODUCTS | STANFORD RES INST INT (US) | 1984-03-29 | — | — | WO | claimed |
| WO-1984001162-A1 | LIQUID CRYSTALLINE POLYMER COMPOSITIONS, PROCESS, AND PRODUCTS | STANFORD RES INST INT (US) | 1984-03-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12441745-B2 | Processes and compounds | ESR1, ESR2, CYP19A1 | PEPD 606/4885ALDH1A1 546/4885LMNA 2261/4885 |
| US-20220162233-A1 | PROCESSES AND COMPOUNDS | ESR1, ESR2, CYP19A1 | PEPD 606/4885ALDH1A1 546/4885LMNA 2261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.